Literature DB >> 31176457

Anorexia and the Cancer Patient.

Chad M Johannes1, Margaret L Musser2.   

Abstract

Appetite influences perceived quality of life for a dog or cat with cancer. Inappetence often is multifactorial, complicating treatment. Cancer-related anorexia/cachexia syndrome is a metabolic, paraneoplastic syndrome characterized by decreased food intake, involuntary weight loss, and loss of fat and muscle. If weight loss/cachexia has an impact on canine and feline cancer patients as in humans, management may improve survival times and quality of life. The challenge is having effective, proved therapies available for clinical use. Recent Food and Drug Administration approvals for appetite stimulation have renewed interest and discussion and has the potential to alter the course of case management.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anorexia; Cachexia; Cancer; Capromorelin; Ghrelin; Inappetence; Mirtazapine

Mesh:

Substances:

Year:  2019        PMID: 31176457     DOI: 10.1016/j.cvsm.2019.04.008

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  3 in total

Review 1.  Cutaneous melanoma dissemination is dependent on the malignant cell properties and factors of intercellular crosstalk in the cancer microenvironment (Review).

Authors:  Ondřej Kodet; Jan Kučera; Karolína Strnadová; Barbora Dvořánková; Jiří Štork; Lukáš Lacina; Karel Smetana
Journal:  Int J Oncol       Date:  2020-06-26       Impact factor: 5.650

2.  Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients.

Authors:  Clara Martín-Carrasco; Pablo Delgado-Bonet; Beatriz Davinia Tomeo-Martín; Josep Pastor; Claudia de la Riva; Paula Palau-Concejo; Noemí Del Castillo; Javier García-Castro; Ana Judith Perisé-Barrios
Journal:  Vet Sci       Date:  2022-06-28

3.  Effect of the liquid form of traditional Chinese medicine, Hozen-S, on gastric motility in dogs.

Authors:  Yuta Shinohara; Mohamed Elbadawy; Megumi Yamanaka; Haru Yamamoto; Amira Abugomaa; Tatsuya Usui; Kazuaki Sasaki
Journal:  J Vet Med Sci       Date:  2022-04-27       Impact factor: 1.105

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.